Ted L. Underiner
Worldwide Clinical Trials (United States)(US)
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, HER2/EGFR in Cancer Research, Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis, Computational Drug Discovery Methods
Most-Cited Works
- → Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates(2010)132 cited
- → Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells(2005)105 cited
- → Diels-Alder approach to bicyclic .alpha.-hydroxy ketones. Facile ketol rearrangements of strained .alpha.-hydroxy ketones(1985)61 cited
- → Designing Chemical Libraries for Lead Discovery(1996)55 cited
- → Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity(2010)49 cited
- → Alkylation of allylic derivatives. 17. Cross-coupling reactions of diallylic pivalates with butyl- and phenylcopper reagents(1991)45 cited
- → Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent(2011)42 cited
- → Alkylation of allylic derivatives. 14. Relationship of double-bond configuration between reactant and product for cross-coupling reactions of Z-allylic carboxylates with organocopper reagents(1989)39 cited
- → Stabilization demands of diethyl phosphonate substituted carbocations as revealed by substituent effects(1985)36 cited
- → First Synthesis of Cytotoxic 8,9-Secokaurene Diterpenoids. An Enantioselective Route to (−)-O-Methylshikoccin and (+)-O-Methylepoxyshikoccin(1997)32 cited